Latest Integral membrane proteins Stories
Many Alzheimer’s disease researchers are focused on stopping the buildup of amyloid plaques, dense protein deposits that are a telltale sign of the debilitating disease. However, a group of scientists from the Salk Institute for Biological Studies decision to think outside the box and pursue a different treatment strategy has paid off.
“Outsourced Ion Channel Testing Trends 2013” is the new market research report added to ReportsnReports.com store. Dallas, Texas (PRWEB) May 03, 2013
Australian researchers have reported significant progress in developing a biomarker blood test that can predict the onset of Alzheimer’s in an individual as much as 17 years before symptoms appear.
For the first time, researchers at Karolinska Institutet in Sweden have managed to obtain detailed images of the way in which the transport protein GLUT transports sugars into cells.
New research published Thursday in the journal Neuron sheds new light on the molecular causes of Alzheimer’s disease, while also revealing a potential new therapy which could help prevent cognitive decline and brain damage during the early stages of the neurodegenerative disorder.
New IBN Peptides May Help Researchers Combat Alzheimer's, Diabetes and CancerSingapore, Apr 22, 2013 - (ACN Newswire) - Amyloids, or fibrous aggregates of abnormally folded
Evidence indicates that the accumulation of amyloid-beta proteins, which form the plaques found in the brains of Alzheimer's patients, is critical for the development of Alzheimer's disease, which impacts 5.4 million Americans.
A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer's disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease.
A new study has shown that heart, blood, lung and other cells have the same receptors for sensing odors that are present in the nose.